Today, the CFO of Mesa Laboratories (NASDAQ: MLAB), John Sakys, sold shares of MLAB for $203.5K.
Following John Sakys’ last MLAB Sell transaction on August 01, 2018, the stock climbed by 14.7%. This is Sakys’ first Sell trade following 4 Buy transactions.
See today’s analyst top recommended stocks >>
Based on Mesa Laboratories’ latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $25.14 million and quarterly net profit of $4.23 million. In comparison, last year the company earned revenue of $22.67 million and had a net profit of $1.52 million. Currently, Mesa Laboratories has an average volume of 10.75K.
In the last 30 days, insiders have sold $203.5K worth of MLAB shares and purchased $73.08K worth of MLAB shares. The insider sentiment on Mesa Laboratories has been negative according to 26 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Mesa Laboratories, Inc. engages in the design, manufacture, and marketing of instruments and disposable products utilized in healthcare, pharmaceutical, food, and beverage, medical device, and petrochemical industries. It operates through the following segments: Sterilization and Disinfection, Instruments, Cold Chain Monitoring, and Cold Chain Packaging.
